Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BMED declined for three days, in 216 of 279 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on BMED as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for BMED just turned positive on October 15, 2026. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 226 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ILMN declined for three days, in 254 of 330 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The 10-day RSI Indicator for ILMN moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 14 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ILMN as a result. In 67 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for ILMN turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 43 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
ILMN broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +10.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in 199 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 184 of 214 cases where ILMN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 86%.
The Tickeron Price Growth Rating for this company is 2 (best 1 - 100 worst), indicating outstanding price growth. ILMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.472) is normal, around the industry mean (72.578). P/E Ratio (50.728) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (3.355) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (7.843) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
ILMN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 31 | |
PRICE GROWTH RATING 1..100 | 2 | |
P/E GROWTH RATING 1..100 | 3 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BMED | ILMN | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 54% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 74% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 78% |
| Advances ODDS (%) | 3 days ago 81% | 13 days ago 73% |
| Declines ODDS (%) | 5 days ago 77% | 2 days ago 77% |
| BollingerBands ODDS (%) | N/A | 2 days ago 75% |
| Aroon ODDS (%) | N/A | 2 days ago 86% |
A.I.dvisor tells us that BMED and BRKR have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and BRKR's prices will move in lockstep.
| Ticker / NAME | Correlation To BMED | 1D Price Change % | ||
|---|---|---|---|---|
| BMED | 100% | -1.45% | ||
| BRKR - BMED | 19% Poorly correlated | -3.08% | ||
| MCRB - BMED | 13% Poorly correlated | -2.77% | ||
| ILMN - BMED | 13% Poorly correlated | -2.01% | ||
| BDX - BMED | 12% Poorly correlated | -1.04% | ||
| CNMD - BMED | 11% Poorly correlated | -0.89% | ||
More | ||||